Document is current
Any future updates will be listed below
-
Authors
Abujudeh, Sam http://orcid.org/0000-0002-1127-4299
Zeki, Sebastian S.
van Lanschot, Meta C.J.
Pusung, Mark
Weaver, Jamie M.J.
Li, Xiaodun
Noorani, Ayesha
Metz, Andrew J.
Bornschein, Jan
Bower, Lawrence
Miremadi, Ahmad
Fitzgerald, Rebecca C.
Morrissey, Edward R.
Lynch, Andy G.
-
Funding
Funding for this research was provided by:
Wellcome Trust (RG73199)
Cancer Research UK (RG66287)
- License Information
-
More Information
Article History
Received: 17 May 2021
Accepted: 10 June 2022
First Online: 17 August 2022
Declarations
:
: The study was registered (UKCRNID 8880) and approved by the Institutional Ethics Committees; BEST2: East of England–Cambridge Central Research Ethics Committee (No: 10/H0308/71), and OCCAMS: Oesophageal Cancer Clinical and Molecular Stratification (REC 07/ H0305/52 and 10/H0305/1). Written and informed consent to participate was obtained from all participants in the study.
: Written and informed consent to participate was obtained from all participants in the study.
: RCF is named on patents related to Cytosponge and related assays that have been licensed to Covidien now Medtronic, and she is a shareholder in Cyted Ltd.
